Literature DB >> 6248464

Initial kinetics of lysosomal enzyme secretion and superoxide anion generation by human polymorphonuclear leukocytes.

J E Smolen, H M Korchak, G Weissmann.   

Abstract

Human polymorphonuclear leukocytes (PMN) exposed to particulate and soluble stimuli secrete lysosomal enzymes. These stimuli cause prompt (less than 10 sec) changes in membrane potential followed 30--45 sec later by superoxide anion (O-2.) production. We describe a new technique utilizing flow dialysis apparatus which monitors the first stages of lysosomal enzyme release with a resolution of approximately 6 sec. Secretion of beta-glucuronidase from cytochalasin B-treated PMN could be detected 19+/-5 sec after exposure to the chemotactic peptide N-formylmethionylleucylphenylalanine (FMLP). The "lag" times for release of this enzyme were different for other stimuli: 35+/-8 sec (BSA/anti-BSA immune complex); 48+/-8 sec (serum-treated zymosan, "STZ"); 60+/-25 sec (calcium ionophore A23187). The lag times for lysozyme release were less dependent upon the stimulus presented (28+/-16 sec for FMLP, 28+/-8 sec fo BSA/anti-BSA, 32+/-10 sec for STZ, and 38+/-8 seconds for Con A); only A23187 had a long lag period: 74+/-27 sec. Lag periods for the onset of O-2. production (measured by the same mathematical criteria) were comparable to those for beta-glucuronidase release: 21+/-4 sec for FMLP, 43+/-14 sec for BSA/anti-BSA, 62+/-7 sec for Con A, and 50+/-13 sec for A23187. Changes in FMLP dose up to 100-fold affected the magnitudes of O-2. generation and beta-glucuronidase release, but did not alter the time required for the onset of these processes. A variety of agents, such as corticosteroids, colchicine, 2-deoxyglucose, and N-ethyl maleimide, also affected the magnitudes of the responses, but not the lag periods when FMLP was used as the stimulus. When BSA/anti-BSA immune complex was used as the stimulus, 2-deoxyglucose and N-ethyl maleimide increased the lag period for superoxide anion generation, but not for lysosomal enzyme release. This new flow dialysis technique has permitted us to demonstrate the O-2. production and lysosomal enzyme secretion are concurrent but dissociable processes which are subsequent to earlier responses of the granulocyte-to-ligand-receptor interactions as reflected by changes in membrane potential.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248464     DOI: 10.1007/bf00914161

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  13 in total

1.  Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system.

Authors:  H J Cohen; M E Chovaniec
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement.

Authors:  I Goldstein; S Hoffstein; J Gallin; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Use of 1-anilino-8-naphtalene sulfonate to study structural transitions in cell membrane of PMN leucocytes.

Authors:  D Romeo; R Cramer; F Rossi
Journal:  Biochem Biophys Res Commun       Date:  1970-11-09       Impact factor: 3.575

5.  Binding of diffusible molecules by macromolecules: rapid measurement by rate of dialysis.

Authors:  S P Colowick; F C Womack
Journal:  J Biol Chem       Date:  1969-02-25       Impact factor: 5.157

6.  Raipid stimulation of protein carboxymethylation in leukocytes by a chemotatic peptide.

Authors:  R F O'Dea; O H Viveros; J Axelrod; S Aswanikaumar; E Schiffmann; B A Corcoran
Journal:  Nature       Date:  1978-03-30       Impact factor: 49.962

7.  H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors.

Authors:  R K Root; J Metcalf; N Oshino; B Chance
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

8.  Changes in membrane potential of human granulocytes antecede the metabolic responses to surface stimulation.

Authors:  H M Korchak; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

9.  Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes.

Authors:  G Brittinger; R Hirschhorn; S D Douglas; G Weissmann
Journal:  J Cell Biol       Date:  1968-05       Impact factor: 10.539

10.  Sequential degranulation of the two types of polymorphonuclear leukocyte granules during phagocytosis of microorganisms.

Authors:  D F Bainton
Journal:  J Cell Biol       Date:  1973-08       Impact factor: 10.539

View more
  10 in total

1.  Silibinin (Legalon-70) enhances the motility of human neutrophils immobilized by formyl-tripeptide, calcium ionophore, lymphokine and by normal human serum.

Authors:  L Kalmár; J Kádár; A Somogyi; P Gergely; G Csomós; J Fehér
Journal:  Agents Actions       Date:  1990-03

2.  Rapid changes in light scattering from human polymorphonuclear leukocytes exposed to chemoattractants. Discrete responses correlated with chemotactic and secretory functions.

Authors:  I Yuli; R Snyderman
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

3.  Relationship between the transient cAMP increase, exocytosis from specific and azurophil granules and chemotaxis in neutrophil granulocytes.

Authors:  A Naef; B Damerau; H U Keller
Journal:  Agents Actions       Date:  1984-01

4.  Pathogenesis of inflammation. Effects of the pharmacological manipulation of arachidonic acid metabolism on the cytological response to inflammatory stimuli.

Authors:  G Weissmann
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Calmodulin-dependency of human neutrophil phosphodiesterase.

Authors:  T Engerson; J L Legendre; H P Jones
Journal:  Inflammation       Date:  1986-03       Impact factor: 4.092

6.  Human neutrophil phosphodiesterase. Calmodulin insensitivity and other properties.

Authors:  J E Smolen; S J Geosits
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

7.  [The therapy of pain in rheumatic joint-and spine diseases.].

Authors:  H Mathies
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

8.  Inhibition of superoxide anion release from human polymorphonuclear leukocytes by N-acetyl-galactosamine and N-acetyl-glucosamine.

Authors:  M Kamel; M Alnahdi
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

9.  Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms.

Authors:  L C McPhail; R Snyderman
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

10.  Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.

Authors:  E A Ham; D D Soderman; M E Zanetti; H W Dougherty; E McCauley; F A Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.